Wire · opportunities
Virtuoso robot wins FDA nod for bladder tumor removal
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 10 November 2026 · Fusion42 review
The FDA granted de novo authorization to Virtuoso Surgical’s robotic system for minimally invasive en bloc resection of bladder tumors, allowing tumors to be removed intact through the urethra using miniaturized robotic arms. This new classification covers electromechanical surgical systems used in endoluminal procedures, enhancing diagnostic accuracy for bladder cancer.
This Wire brief sits within Fusion42's coverage of Medtech, and 5 sources have reported it between 10 Nov 2026 and 16 Nov 2026.
◆ ◆ The Wire takeaway
You now face a new FDA-approved robot platform that can improve bladder cancer diagnosis by preserving tissue better. Rapidly explore integration or partnership opportunities before competitors capture this endoluminal surgery niche.
◆ Coverage
5 sources · first reported 10 Nov 2026 · latest 16 Nov 2026
◆ Related on Wire
◆ Topics